HENNEMAN JOHN B III - Insider Non-Derivative Transactions at Anika Therapeutics, Inc. (ANIK) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 20, 2025, HENNEMAN JOHN B III's relationship to Anika Therapeutics, Inc. (ANIK) is Director, and currently has 49,871 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ANIK insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

HENNEMAN JOHN B III - Insider Non-Derivative Transactions of ANIK Common Stock

HENNEMAN JOHN B III - Insider Non-Derivative Transactions at ANIK

Items per page:

0 of 0

Date	Transaction	No. of Shares	Shares Owned After Transactions
Jun 21, 2025	Acquisition -- (Common Stock)	14164	49871
Jul 10, 2024	Acquisition -- (Common Stock)	5771	35707
Jun 15, 2023	Acquisition -- (Common Stock)	6500	29936